ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,774Medicare Part D Prescriptions Filled, Including Refills

Rank: 297 out of 1677

$560K Total Retail Price of All Prescriptions

Rank: 291 out of 1677

484 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 8,849 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 478 392 1 5
GABAPENTIN 379 279 2 11
SIMVASTATIN 355 322 3 1
LISINOPRIL 346 283 4 3
PRAVASTATIN SODIUM 281 229 5 10
METFORMIN HCL 269 229 6 7
OMEPRAZOLE 258 188 7 6
METOPROLOL TARTRATE 258 237 7 12
MELOXICAM 201 152 9 27
AMLODIPINE BESYLATE 186 170 10 2
WARFARIN SODIUM 178 178 11 24
HYDROCHLOROTHIAZIDE 159 137 12 9
METOPROLOL SUCCINATE 155 144 13 23
LOSARTAN POTASSIUM 151 148 14 25
SERTRALINE HCL 146 133 15 26
ATENOLOL 145 135 16 21
NEXIUM 145 129 16 19
AMITRIPTYLINE HCL 137 125 R 18 63
HYDROCODONE-ACETAMINOPHEN 130 81 S3 19 4
FUROSEMIDE 129 108 20 8
ATORVASTATIN CALCIUM 124 114 21 13
POTASSIUM CHLORIDE 120 88 22 14
CITALOPRAM HBR 113 69 23 22
FLUTICASONE PROPIONATE 113 81 23 29
TRAMADOL HCL 104 95 25 16
FLUOXETINE HCL 102 81 26 49
CRESTOR 98 63 27 28
GEMFIBROZIL 96 85 28 113
CYMBALTA 93 72 29 58
PANTOPRAZOLE SODIUM 90 88 30 46
DICLOFENAC SODIUM 90 80 30 95
SULFAMETHOXAZOLE-TRIMETHOPRIM 89 66 32 85
FENOFIBRATE 83 71 33 48
BENAZEPRIL HCL 81 64 34 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 72 35 17
PAROXETINE HCL 78 69 36 67
ALLOPURINOL 71 63 37 31
TRAZODONE HCL 70 66 38 37
DONEPEZIL HCL 69 69 39 30
CARVEDILOL 67 59 40 20
ZOLPIDEM TARTRATE 66 32 41 15
LOSARTAN-HYDROCHLOROTHIAZIDE 65 62 42 42
SYNTHROID 60 57 43 55
ALENDRONATE SODIUM 59 52 44 43
VERAPAMIL ER 58 48 45 86
LEVOFLOXACIN 57 47 46 84
DIOVAN HCT 56 48 47 66
CIPROFLOXACIN HCL 56 46 47 57
PREDNISONE 55 48 49 40
DILTIAZEM ER 55 55 49 143
PROAIR HFA 53 38 51 50
ZETIA 51 49 52 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.